Aerie Pharmaceuticals
Bedminster, New Jersey, United States
About Aerie Pharmaceuticals
Aerie Pharmaceuticals is a biotechnology company that engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases. The company was founded in 2005 and is headquartered in Bridgewater, New Jersey with research facilities in Research Triangle Park, North Carolina. Aerie Pharmaceuticals, Inc. is a former subsidiary of Duke University Medical Center.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $1.0B
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2021)
- Ticker: nasdaq:AERI
- Website: aeriepharma.com
- Phone: (908) 470-4320
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aerie-pharmaceuticals-2254081 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.